Relation of Plasma Glycine, Serine, and Homocysteine Levels to Schizophrenia Symptoms and Medication Type

OBJECTIVE: Altered glycine and homocysteine levels may contribute to N-methyl-d-aspartate receptor dysfunction in schizophrenia. The authors measured plasma levels of these amino acids in a group of patients with chronic schizophrenia and related them to the patients' symptom profiles and types...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of psychiatry Vol. 162; no. 9; pp. 1738 - 1740
Main Authors Neeman, Guy, Blanaru, Monica, Bloch, Boaz, Kremer, Ilana, Ermilov, Marina, Javitt, Daniel C., Heresco-Levy, Uriel
Format Journal Article
LanguageEnglish
Published Washington, DC American Psychiatric Publishing 01.09.2005
American Psychiatric Association
Subjects
Online AccessGet full text
ISSN0002-953X
1535-7228
DOI10.1176/appi.ajp.162.9.1738

Cover

More Information
Summary:OBJECTIVE: Altered glycine and homocysteine levels may contribute to N-methyl-d-aspartate receptor dysfunction in schizophrenia. The authors measured plasma levels of these amino acids in a group of patients with chronic schizophrenia and related them to the patients' symptom profiles and types of antipsychotic medication. METHOD: Plasma levels of amino acids in 94 patients with schizophrenia were compared with those in 34 age- and sex-matched normal subjects. The Positive and Negative Syndrome Scale was used to evaluate the patients' psychopathology. RESULTS: Plasma glycine levels and glycine-serine ratios were lower and homocysteine levels were higher in patients than in comparison subjects. Low glycine levels correlated with a greater number of negative symptoms. The glycine-serine ratios of normal subjects and patients being treated with clozapine did not differ significantly. CONCLUSIONS: These findings support the hypothesis that altered levels of glycine and homocysteine may coexist in patients with schizophrenia and contribute to pathophysiological aspects of this illness.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
ISSN:0002-953X
1535-7228
DOI:10.1176/appi.ajp.162.9.1738